Xenotransplantation最新文献

筛选
英文 中文
Human Hematopoietic Stem Cell Engraftment and Differentiation in Immunodeficient Pigs. 人造血干细胞在免疫缺陷猪体内的植入与分化。
IF 4.1 4区 医学
Xenotransplantation Pub Date : 2025-09-01 DOI: 10.1111/xen.70077
Chen-Chen Pi, Jun Zou, Minghui Fang, Zheng Hu, Yong-Guang Yang
{"title":"Human Hematopoietic Stem Cell Engraftment and Differentiation in Immunodeficient Pigs.","authors":"Chen-Chen Pi, Jun Zou, Minghui Fang, Zheng Hu, Yong-Guang Yang","doi":"10.1111/xen.70077","DOIUrl":"10.1111/xen.70077","url":null,"abstract":"<p><p>Immunodeficient large animals that allow engraftment of human tissues and cells are highly valuable for translational studies. Recently, a strain of immunodeficient pigs (termed RGD pigs) was developed through the genetic inactivation of RAG1, IL2RG, and CD47. These RGD pigs lack functional T, B, and NK cells and do not exhibit CD47-SIRPα incompatibility-triggered macrophage xenoresponses. Transplantation of human hematopoietic stem/progenitor cells (HSPCs) into RGD pigs results in high levels of durable human hematopoietic engraftment and systemic repopulation with multilineage human lymphohematopoietic cells, including T, B, NK, and myeloid cells. The transplanted pigs maintain robust human hematopoiesis in the bone marrow (BM) and ongoing thymopoiesis in the thymus. Human T and B cells developing in these pigs express broad antigen receptor repertoires and exhibit tolerance to the recipient pig. The RGD pig is considered a valuable preclinical model for investigating normal or diseased human hematopoiesis and related therapies, and offers a potential bioreactor for large-scale production of human immune cells. These pigs are also highly valuable for in vivo studies on other types of human tissues and cells.</p>","PeriodicalId":23866,"journal":{"name":"Xenotransplantation","volume":"32 5","pages":"e70077"},"PeriodicalIF":4.1,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145065760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IXA 2025 Congress. IXA 2025大会。
IF 4.1 4区 医学
Xenotransplantation Pub Date : 2025-09-01 DOI: 10.1111/xen.70067
{"title":"IXA 2025 Congress.","authors":"","doi":"10.1111/xen.70067","DOIUrl":"https://doi.org/10.1111/xen.70067","url":null,"abstract":"","PeriodicalId":23866,"journal":{"name":"Xenotransplantation","volume":"32 Suppl 1 ","pages":"e70067"},"PeriodicalIF":4.1,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145207824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Which Platform of SARS-CoV-2 Vaccines Should be Used for Xenotransplant Recipients? 异种移植受者应使用哪个平台的SARS-CoV-2疫苗?
IF 4.1 4区 医学
Xenotransplantation Pub Date : 2025-09-01 DOI: 10.1111/xen.70086
Shu Yuan, Zhong-Wei Zhang, Si-Cong Jiang
{"title":"Which Platform of SARS-CoV-2 Vaccines Should be Used for Xenotransplant Recipients?","authors":"Shu Yuan, Zhong-Wei Zhang, Si-Cong Jiang","doi":"10.1111/xen.70086","DOIUrl":"https://doi.org/10.1111/xen.70086","url":null,"abstract":"","PeriodicalId":23866,"journal":{"name":"Xenotransplantation","volume":"32 5","pages":"e70086"},"PeriodicalIF":4.1,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145293849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-Cell RNA Analysis Reveals Reduced Frequency and Activity of CXCR5+ Atypical Memory B Cells in Islet Xenotransplantation Treated With Clinically Applicable Immunosuppressants Including Belimumab. 单细胞RNA分析显示,在临床适用的免疫抑制剂包括Belimumab治疗的胰岛异种移植中,CXCR5+非典型记忆B细胞的频率和活性降低
IF 4.1 4区 医学
Xenotransplantation Pub Date : 2025-09-01 DOI: 10.1111/xen.70076
Yuji Lee, Ji Hwan Moon, Hyun Je Kim, Daesik Kim, Yong-Hee Kim, Jong-Min Kim, Chung-Gyu Park
{"title":"Single-Cell RNA Analysis Reveals Reduced Frequency and Activity of CXCR5<sup>+</sup> Atypical Memory B Cells in Islet Xenotransplantation Treated With Clinically Applicable Immunosuppressants Including Belimumab.","authors":"Yuji Lee, Ji Hwan Moon, Hyun Je Kim, Daesik Kim, Yong-Hee Kim, Jong-Min Kim, Chung-Gyu Park","doi":"10.1111/xen.70076","DOIUrl":"10.1111/xen.70076","url":null,"abstract":"<p><strong>Background: </strong>Porcine-to-human islet xenotransplantation offers a promising solution to type 1 diabetes. This study investigates the use of Belimumab, a human monoclonal antibody that inhibits B cell activating factor (BAFF) as part of an immunosuppressive regimen in porcine-to-non-human primate xenotransplantation.</p><p><strong>Methods: </strong>Porcine islets were transplanted into Rhesus monkeys with an immunosuppressant regimen. Blood samples were collected from the monkeys pre- and post-treatment, and single-cell RNA sequencing was performed to investigate immune cell landscape changes, focusing on B cells.</p><p><strong>Results: </strong>UMAP clustering of B cells identified five distinct subsets. Notably, Belimumab treatment significantly reduced the proportion of both CXCR5<sup>+</sup> and CXCR5<sup>-</sup> atypical memory B cells, which possess the potential to differentiate into antibody-secreting cells. Furthermore, differentially expressed gene (DEG) analysis revealed a comprehensive functional impairment, along with significant downregulation of activation markers such as CD69 and CD83, across all B cell subsets.</p><p><strong>Conclusions: </strong>Our study elucidates the mechanism of action of Belimumab in non-human primate models, serving as preclinical subjects for B-cell-targeted therapy research in a xenotransplantation context. Significantly, our data indicate that Belimumab not only reduces the proportion of antibody-secreting atypical memory B cells but also induces functional impairment across all B cell subsets. Given the potential pathogenic roles of atypical memory B cells in autoimmunity and other related settings, their reduction by Belimumab could play a crucial role in regulating B-cell-mediated immune responses in pig-to-non-human primate pancreatic islet xenotransplantation. Thus, our findings highlight the prospective utility of Belimumab as a B cell suppressant in future clinical xenotransplantation applications.</p>","PeriodicalId":23866,"journal":{"name":"Xenotransplantation","volume":"32 5","pages":"e70076"},"PeriodicalIF":4.1,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12498312/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145081725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complement Inhibition in Xenotransplantation-Where Should the Complement Cascade be Inhibited? 异种移植中的补体抑制——补体级联应该在哪里被抑制?
IF 4.1 4区 医学
Xenotransplantation Pub Date : 2025-09-01 DOI: 10.1111/xen.70087
Akihiro Maenaka, Kohei Kinoshita, David K C Cooper
{"title":"Complement Inhibition in Xenotransplantation-Where Should the Complement Cascade be Inhibited?","authors":"Akihiro Maenaka, Kohei Kinoshita, David K C Cooper","doi":"10.1111/xen.70087","DOIUrl":"https://doi.org/10.1111/xen.70087","url":null,"abstract":"<p><p>Clinical gene-edited pig organ xenotransplantation has recently become a reality, but some problems remain. The transgenic expression of human complement-regulatory proteins in the pig organs is now an accepted means of reducing the impact of complement activation, and immunosuppressive therapy based on CD40/CD154 co-stimulation pathway blockade has proven a largely effective regimen. However, the potential role of complement inhibitors remains uncertain. The complement cascade is complex and consists of several major pathways (e.g., classical, lectin, alternative, terminal) but with several amplification loops and bypasses. It can be inhibited at several different sites, for example, C1, C3, C5, Factor B, and Factor D. We discuss the effect of the various inhibitors currently available and consider their advantages and disadvantages in relation to xenotransplantation. We tentatively suggest that a C3/C3b complement inhibitor may prove optimal, and that complement inhibition may need to be extended for a prolonged period of time.</p>","PeriodicalId":23866,"journal":{"name":"Xenotransplantation","volume":"32 5","pages":"e70087"},"PeriodicalIF":4.1,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145293811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biocompatibility of Genetically-Engineered Pig Cornea in Corneal Xenotransplantation: Preliminary In Vitro Study. 基因工程猪角膜异种角膜移植生物相容性的初步体外研究。
IF 4.1 4区 医学
Xenotransplantation Pub Date : 2025-09-01 DOI: 10.1111/xen.70081
Seung Hyeun Lee, Chung Young Kim, Jin Suk Ryu, Dong Hee Choi, Chang Ho Yoon, Chung-Gyu Park, Kimyung Choi, Hyunil Kim, Mee Kum Kim
{"title":"Biocompatibility of Genetically-Engineered Pig Cornea in Corneal Xenotransplantation: Preliminary In Vitro Study.","authors":"Seung Hyeun Lee, Chung Young Kim, Jin Suk Ryu, Dong Hee Choi, Chang Ho Yoon, Chung-Gyu Park, Kimyung Choi, Hyunil Kim, Mee Kum Kim","doi":"10.1111/xen.70081","DOIUrl":"10.1111/xen.70081","url":null,"abstract":"<p><strong>Introduction: </strong>We aimed to evaluate biophysical compatibility of corneal endothelial cells in genetically-engineered (GE) pigs to identify the best candidate for in vivo nonhuman primate (NHP) study and to collect baseline data for future clinical trials from a biological function perspective.</p><p><strong>Methods: </strong>Triple or quadruple knock-out (T[Q]KO) pigs with inactivation of α1,3-galactosyltransferase (GGTA1), cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMAH), β1,4-N-acetylgalactosaminyltransferase (β4GalNT2), and/or isoglobotrihexosylceramide synthase (iGB3s) genes were used in combination with insertion of Human(h) CD55, CD39, CD46, and thrombomodulin (TBM) genes. Twenty-seven eyeballs obtained from 14 GE pigs were used to evaluate the physical parameters and functional properties as a suitable donor. Corneal endothelial cell density (ECD) was serially measured for 7 days in a preservative solution. Doubling time (DT) for EC proliferation and immunofluorescence staining of corneal endothelial pump channels and tight junctional proteins were evaluated.</p><p><strong>Results: </strong>Mean age of GE pigs was 11.9 months old and mean central corneal thickness was 718.2 µm. Mean ECD loss/week was significantly higher in GE pigs younger than 6 months, which was 55.1%, while it was 8.8% in GE pigs older than 6 months (p < 0.001). T(Q)KO/hCD46/hTBM cornea showed early severe apoptotic or necrotic changes of endothelial cells, whereas other GE corneas did not. Although the mean DT increased in all GE pigs, it showed no difference between the younger and older groups. ZO-1, N-cadherin, ATPase, SLC4A1, and aquaporin 1 were well expressed on endothelial cells regardless of modified gene types.</p><p><strong>Conclusion: </strong>It suggests that no effect of the added gene was observed on the endothelial cell functional capacities in TKO(QKO) pig corneas, and GE pigs over 6 months old are suitable as corneal transplant donors.</p>","PeriodicalId":23866,"journal":{"name":"Xenotransplantation","volume":"32 5","pages":"e70081"},"PeriodicalIF":4.1,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12454731/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145126269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to "Defect in Sensing Human Thrombin by Porcine Endothelial Protease-Activated Receptor-1: Molecular Incompatibility between Porcine PAR-1 and Human Thrombin". 修正“猪内皮蛋白酶激活受体-1感知人凝血酶的缺陷:猪PAR-1与人凝血酶的分子不相容性”。
IF 4.1 4区 医学
Xenotransplantation Pub Date : 2025-09-01 DOI: 10.1111/xen.70066
{"title":"Correction to \"Defect in Sensing Human Thrombin by Porcine Endothelial Protease-Activated Receptor-1: Molecular Incompatibility between Porcine PAR-1 and Human Thrombin\".","authors":"","doi":"10.1111/xen.70066","DOIUrl":"https://doi.org/10.1111/xen.70066","url":null,"abstract":"","PeriodicalId":23866,"journal":{"name":"Xenotransplantation","volume":"32 5","pages":"e70066"},"PeriodicalIF":4.1,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145081729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cellular Landscapes of Different Gene-Edited Pig Hearts Associated With Cardiac Xenotransplantation. 与心脏异种移植相关的不同基因编辑猪心脏的细胞景观。
IF 4.1 4区 医学
Xenotransplantation Pub Date : 2025-09-01 DOI: 10.1111/xen.70088
Hang Zhang, Shen Song, Xiao Chen, Ning-Ning Zhang, Xiu-Meng Hua, Yuan Chang, Zhen-Yu Xu, Sheng-Shou Hu, Jiang-Ping Song
{"title":"Cellular Landscapes of Different Gene-Edited Pig Hearts Associated With Cardiac Xenotransplantation.","authors":"Hang Zhang, Shen Song, Xiao Chen, Ning-Ning Zhang, Xiu-Meng Hua, Yuan Chang, Zhen-Yu Xu, Sheng-Shou Hu, Jiang-Ping Song","doi":"10.1111/xen.70088","DOIUrl":"https://doi.org/10.1111/xen.70088","url":null,"abstract":"<p><p>Gene-edited pigs are currently considered the most appropriate donors for cardiac xenotransplantation. Although gene editing has improved donor-recipient compatibility, the effects of gene editing on donor organs, and the comprehensive cellular landscape of different gene-edited pig hearts remain unclear. This study characterized the cardiomyocyte and non-cardiomyocyte cellular landscape of wild-type (WT), alpha 1-3 galactosyltransferase gene knockout (GTKO), and triple gene edited (3GE: GTKO·hCD46·hTBM) porcine hearts using single-nucleus RNA sequencing (snRNA-seq) and single-cell RNA sequencing (scRNA-seq). We identified seven major cell types, including cardiomyocyte, fibroblast, endothelial cell, smooth muscle cell, macrophage, T lymphocyte, and pericyte. Integrative analysis revealed significantly more profound transcriptomic alterations in hearts from 3GE pigs compared to those from GTKO pigs. Cellular heterogeneity within cardiomyocytes and non-cardiomyocytes was identified, and pathological staining validated key sequencing findings. Analyses of cell-to-cell interactions identified the core position of cardiomyocytes and fibroblasts in intercellular communications, alongside the characteristic cellular interactions within each genotype. Transcriptomic differences at the transcriptomic level between porcine and normal human hearts were also compared. Our data revealed key cell subsets potentially involved in immune rejection and cardiac hypertrophy in cardiac xenotransplantation. This approach also provides a foundation for applying transcriptomic analysis to donor pigs with increasingly complex genetic modifications, enabling unbiased documentation of transgene expression and assessment of the impact of multigene engineering on endogenous cardiac gene expression.</p>","PeriodicalId":23866,"journal":{"name":"Xenotransplantation","volume":"32 5","pages":"e70088"},"PeriodicalIF":4.1,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145293868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rural Transplant Disparities and Xenotransplantation: Scaling Is Not Enough. 农村移植差异和异种移植:规模是不够的。
IF 4.1 4区 医学
Xenotransplantation Pub Date : 2025-09-01 DOI: 10.1111/xen.70083
Priya Dutta, Christopher Bobier
{"title":"Rural Transplant Disparities and Xenotransplantation: Scaling Is Not Enough.","authors":"Priya Dutta, Christopher Bobier","doi":"10.1111/xen.70083","DOIUrl":"https://doi.org/10.1111/xen.70083","url":null,"abstract":"","PeriodicalId":23866,"journal":{"name":"Xenotransplantation","volume":"32 5","pages":"e70083"},"PeriodicalIF":4.1,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145293876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Porcine Cytomegalovirus/Porcine Roseolovirus (PCMV/PRV) and Antiviral Drugs. 猪巨细胞病毒/猪玫瑰红病毒(PCMV/PRV)与抗病毒药物。
IF 4.1 4区 医学
Xenotransplantation Pub Date : 2025-09-01 DOI: 10.1111/xen.70075
Joachim Denner
{"title":"Porcine Cytomegalovirus/Porcine Roseolovirus (PCMV/PRV) and Antiviral Drugs.","authors":"Joachim Denner","doi":"10.1111/xen.70075","DOIUrl":"https://doi.org/10.1111/xen.70075","url":null,"abstract":"","PeriodicalId":23866,"journal":{"name":"Xenotransplantation","volume":"32 5","pages":"e70075"},"PeriodicalIF":4.1,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145016307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信